Barclays’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-700,000	Closed	-$7.35M	–	4447
2023 Q1	$7.35M	Hold	700,000	–	–	﹤0.01%	916
2022 Q4	$7.21M	Hold	700,000	–	–	﹤0.01%	946
2022 Q3	$7.1M	Hold	700,000	–	–	0.01%	936
2022 Q2	$6.99M	Buy	+700,000	New	+$6.99M	﹤0.01%	957